Sarjana Raikwar

447 total citations
21 papers, 232 citations indexed

About

Sarjana Raikwar is a scholar working on Biomaterials, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Sarjana Raikwar has authored 21 papers receiving a total of 232 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Biomaterials, 7 papers in Biomedical Engineering and 6 papers in Molecular Biology. Recurrent topics in Sarjana Raikwar's work include Nanoparticle-Based Drug Delivery (10 papers), RNA Interference and Gene Delivery (4 papers) and Nanoplatforms for cancer theranostics (4 papers). Sarjana Raikwar is often cited by papers focused on Nanoparticle-Based Drug Delivery (10 papers), RNA Interference and Gene Delivery (4 papers) and Nanoplatforms for cancer theranostics (4 papers). Sarjana Raikwar collaborates with scholars based in India and United States. Sarjana Raikwar's co-authors include Tejal Mehta, Amol D. Gholap, Atul Garkal, Satish Rojekar, Harshad S. Kapare, Uday S. Annapure, Harsh B. Jadhav, Preeti Patel, Sanjay Jain and Balak Das Kurmi and has published in prestigious journals such as Carbohydrate Polymers, International Journal of Biological Macromolecules and Expert Opinion on Drug Delivery.

In The Last Decade

Sarjana Raikwar

17 papers receiving 223 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarjana Raikwar India 8 94 78 69 30 17 21 232
Yamin Li China 8 93 1.0× 96 1.2× 57 0.8× 28 0.9× 24 1.4× 16 304
Panpan Song China 9 82 0.9× 96 1.2× 83 1.2× 19 0.6× 19 1.1× 19 291
Nhu‐Thuy Trinh Vietnam 9 103 1.1× 80 1.0× 58 0.8× 28 0.9× 23 1.4× 18 290
Pegah Khosravian Iran 10 115 1.2× 110 1.4× 94 1.4× 22 0.7× 17 1.0× 34 308
Hyeryeon Oh South Korea 12 72 0.8× 63 0.8× 74 1.1× 45 1.5× 13 0.8× 28 290
Samson A. Adeyemi South Africa 11 113 1.2× 78 1.0× 68 1.0× 19 0.6× 18 1.1× 46 299
Evangelos Natsaridis Greece 5 99 1.1× 103 1.3× 91 1.3× 71 2.4× 25 1.5× 10 315
Jessyca Aparecida Paes Dutra Brazil 11 160 1.7× 140 1.8× 116 1.7× 42 1.4× 31 1.8× 22 372
Naveen Rajana India 13 146 1.6× 95 1.2× 101 1.5× 80 2.7× 13 0.8× 22 327
Rabia Gul Pakistan 8 82 0.9× 69 0.9× 37 0.5× 99 3.3× 22 1.3× 17 252

Countries citing papers authored by Sarjana Raikwar

Since Specialization
Citations

This map shows the geographic impact of Sarjana Raikwar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarjana Raikwar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarjana Raikwar more than expected).

Fields of papers citing papers by Sarjana Raikwar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarjana Raikwar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarjana Raikwar. The network helps show where Sarjana Raikwar may publish in the future.

Co-authorship network of co-authors of Sarjana Raikwar

This figure shows the co-authorship network connecting the top 25 collaborators of Sarjana Raikwar. A scholar is included among the top collaborators of Sarjana Raikwar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarjana Raikwar. Sarjana Raikwar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mukherjee, Debanjan, Sarjana Raikwar, Ankit Awasthi, et al.. (2025). Carboplatin Co-loaded 5-Fluorouracil Nanoparticles Conjugated with Trastuzumab for Targeted Therapy in HER2+ Heterogeneity Breast Cancer. AAPS PharmSciTech. 26(5). 114–114. 3 indexed citations
2.
Kaur, Harpreet, et al.. (2025). Tiny Dots, Big Impact: The Antimicrobial Power of Carbon Dots. Anti-Infective Agents. 23(5). 1 indexed citations
3.
Raikwar, Sarjana, et al.. (2025). Emerging Combinatorial Drug Delivery Strategies for Breast Cancer: A Comprehensive Review. Current Drug Targets. 26(5). 331–349. 1 indexed citations
4.
Raikwar, Sarjana, et al.. (2024). Resveratrol: A comprehensive review of its multifaceted health benefits, mechanisms of action, and potential therapeutic applications in chronic disease. Pharmacological Research - Natural Products. 3. 100047–100047. 24 indexed citations
5.
Mukherjee, Debanjan & Sarjana Raikwar. (2024). Recent Update on Nanocarrier(s) as the Targeted Therapy for Breast Cancer. AAPS PharmSciTech. 25(6). 153–153. 5 indexed citations
6.
Panda, Pritish Kumar, Shivani Saraf, Amit Kumar Verma, et al.. (2024). Role of Vitamins in Therapeutic and Targeting Approaches for Prostate Cancer: An Overview. Current Drug Targets. 25(14). 934–952. 1 indexed citations
7.
Sharma, Tarun, et al.. (2024). Targeting to Overexpressed Receptor in Colon Cancer: A Review. 3. 1 indexed citations
8.
Thakur, Shubham, et al.. (2024). Revolutionizing cancer treatment: The role of chitosan nanoparticles in therapeutic advancements. Journal of Drug Delivery Science and Technology. 96. 105661–105661. 12 indexed citations
9.
Gholap, Amol D., Harshad S. Kapare, Sarjana Raikwar, et al.. (2024). Exploring modified chitosan-based gene delivery technologies for therapeutic advancements. International Journal of Biological Macromolecules. 260(Pt 2). 129581–129581. 34 indexed citations
10.
Raikwar, Sarjana, et al.. (2024). Enhancement of Oral Bioavailability of Protein and Peptide byPolysaccharide-based Nanoparticles. Protein and Peptide Letters. 31(3). 209–228. 9 indexed citations
11.
Kumar, Amit, et al.. (2024). Recent Trends in Nanocarrier-Based Drug Delivery System for Prostate Cancer. AAPS PharmSciTech. 25(3). 55–55. 6 indexed citations
12.
Kumar, Amit, Raj Kumar Narang, & Sarjana Raikwar. (2024). Aptamer-modified Nanocarrier(s) for the Management of Prostate Cancer. 15(4). 329–331. 1 indexed citations
13.
14.
Raikwar, Sarjana, et al.. (2024). Revolutionizing Oral Cancer Treatment: Immunotherapeutic Approaches. Current Cancer Therapy Reviews. 21(3). 278–286.
15.
Raikwar, Sarjana, et al.. (2023). Antibody-conjugated pH-sensitive liposomes for HER-2 positive breast cancer: development, characterization, in vitro and in vivo assessment. Journal of Liposome Research. 34(2). 239–263. 4 indexed citations
16.
Gholap, Amol D., Satish Rojekar, Harshad S. Kapare, et al.. (2023). Chitosan scaffolds: Expanding horizons in biomedical applications. Carbohydrate Polymers. 323. 121394–121394. 93 indexed citations
17.
Raikwar, Sarjana, Ankit Jain, Shivani Saraf, et al.. (2022). Opportunities in combinational chemo-immunotherapy for breast cancer using nanotechnology: an emerging landscape. Expert Opinion on Drug Delivery. 19(3). 247–268. 16 indexed citations
18.
Raikwar, Sarjana. (2019). Nanocarrier(s) as an Emerging Platform for Breast Cancer Therapy. Journal of Drug Delivery and Therapeutics. 9. 5–8. 1 indexed citations
19.
Panda, Pritish Kumar, Shivani Saraf, Ankita Tiwari, et al.. (2019). Novel Strategies for Targeting Prostate Cancer. Current Drug Delivery. 16(8). 712–727. 13 indexed citations
20.
Raikwar, Sarjana, et al.. (2018). Nanocarrier-Based Combination Chemotherapy for Resistant Tumor: Development, Characterization, and Ex Vivo Cytotoxicity Assessment. AAPS PharmSciTech. 19(8). 3839–3849. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yamin Li Breakdown of academic impact, for papers by Panpan Song Breakdown of academic impact, for papers by Nhu‐Thuy Trinh Breakdown of academic impact, for papers by Pegah Khosravian Breakdown of academic impact, for papers by Hyeryeon Oh Breakdown of academic impact, for papers by Samson A. Adeyemi Breakdown of academic impact, for papers by Evangelos Natsaridis Breakdown of academic impact, for papers by Jessyca Aparecida Paes Dutra Breakdown of academic impact, for papers by Naveen Rajana Breakdown of academic impact, for papers by Rabia Gul
Rankless by CCL
2026